Form 8-K - Current report:
SEC Accession No. 0000950170-24-117710
Filing Date
2024-10-28
Accepted
2024-10-28 15:59:34
Documents
11
Period of Report
2024-10-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20241024.htm   iXBRL 8-K 68158
  Complete submission text file 0000950170-24-117710.txt   182680

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20241024.xsd EX-101.SCH 25023
13 EXTRACTED XBRL INSTANCE DOCUMENT neog-20241024_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241400809
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)